Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CARCINOMA, PANCREATIC DUCTAL - PATHOLOGY , . Treffer: 9

2020

Golob-Schwarzl, N; Puchas, P; Gogg-Kamerer, M; Weichert, W; Göppert, B; Haybaeck, J New Pancreatic Cancer Biomarkers eIF1, eIF2D, eIF3C and eIF6 Play a Major Role in Translational Control in Ductal Adenocarcinoma.
Anticancer Res. 2020; 40(6):3109-3118
Web of Science PubMed FullText FullText_MUG

 

2017

Mangge, H; Niedrist, T; Renner, W; Lyer, S; Alexiou, C; Haybaeck, J New Diagnostic and Therapeutic Aspects of Pancreatic Ductal Adenocarcinoma.
Curr Med Chem. 2017; 24(28):3012-3024
Web of Science PubMed FullText FullText_MUG

 

2016

Fan, P; Liu, L; Yin, Y; Zhao, Z; Zhang, Y; Amponsah, PS; Xiao, X; Bauer, N; Abukiwan, A; Nwaeburu, CC; Gladkich, J; Gao, C; Schemmer, P; Gross, W; Herr, I MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer.
Cancer Lett. 2016; 373(1):130-137
Web of Science PubMed FullText FullText_MUG

 

Jagadeeshan, S; Subramanian, A; Tentu, S; Beesetti, S; Singhal, M; Raghavan, S; Surabhi, RP; Mavuluri, J; Bhoopalan, H; Biswal, J; Pitani, RS; Chidambaram, S; Sundaram, S; Malathi, R; Jeyaraman, J; Nair, AS; Venkatraman, G; Rayala, SK P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer.
Ann Oncol. 2016; 27(8):1546-1556
Web of Science PubMed FullText FullText_MUG

 

2014

Forster, T; Rausch, V; Zhang, Y; Isayev, O; Heilmann, K; Schoensiegel, F; Liu, L; Nessling, M; Richter, K; Labsch, S; Nwaeburu, CC; Mattern, J; Gladkich, J; Giese, N; Werner, J; Schemmer, P; Gross, W; Gebhard, MM; Gerhauser, C; Schaefer, M; Herr, I Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication.
Oncotarget. 2014; 5(6):1621-1634 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Szkandera, J; Stotz, M; Absenger, G; Stojakovic, T; Samonigg, H; Kornprat, P; Schaberl-Moser, R; Alzoughbi, W; Lackner, C; Ress, AL; Seggewies, FS; Gerger, A; Hoefler, G; Pichler, M Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.
Br J Cancer. 2014; 110(1):183-188 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Stotz, M; Eisner, F; Szkandera, J; Absenger, G; Kornprat, P; Lackner, C; Samonigg, H; Gerger, A; Pichler, M Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.
J Clin Pathol. 2013; 66(9):753-757
Web of Science PubMed FullText FullText_MUG

 

2012

Rausch, V; Liu, L; Apel, A; Rettig, T; Gladkich, J; Labsch, S; Kallifatidis, G; Kaczorowski, A; Groth, A; Gross, W; Gebhard, MM; Schemmer, P; Werner, J; Salnikov, AV; Zentgraf, H; Büchler, MW; Herr, I Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment.
J Pathol. 2012; 227(3):325-335
Web of Science PubMed FullText FullText_MUG

 

2001

Wurzer, H; Brandstätter, G; Worm, HC; Wolf, G Intraductal papillary-mucinous tumors of the pancreas: presentation of eight cases.
Wien Klin Wochenschr. 2001; 113(22):880-884 (- Case Report)
Web of Science PubMed

 

© Med Uni Graz Impressum